Cogent Biosciences at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Cogent Biosciences exhibits at Booth 3812 at ASH 2026 in New Orleans. Cogent Biosciences supports a symposium on systemic mastocytosis. It focuses on the key decision points that shape care across the full range of the disease.
| Organization | ASH 2026 Attendance |
|---|---|
Cogent Biosciences Waltham, MA | |
Biotech developing precision therapies for genetically defined diseases; lead drug bezuclastinib, a mutant-KIT inhibitor, is in late-stage trials for systemic mastocytosis and GIST. | Booth Exhibiting at Booth 3812 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Clinical Turning Points: Decisions That Shape Care Across the Spectrum of Systemic Mastocytosis Recognizing the full symptom burden of non-advanced systemic mastocytosis, judging disease control, and deciding when to escalate to disease-directed therapy. |
Instantly find 20 buyers from Cogent Biosciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction